Mediroza (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
MFDS item code 201402494 · Approved 2014.05.30 · Insurance code 625800110
This product's status changed to Expired on 2024.05.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and type 2 diabetic nephropathy with hypertension
This medication is used for the treatment of hypertension and helps prevent and manage kidney disease in hypertensive patients, especially those with type 2 diabetes. It effectively controls hypertension, reducing the risk of cardiovascular complications and improving blood pressure-related renal function decline. This treatment helps maintain the overall health of patients and prevents the occurrence of complications.
This medication may be taken with or without food, but taking it at the same time each day is recommended. Hypertension, adults: The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to up to 100 mg once daily, if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this medication is 50 mg once daily. The dose may be increased to up to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of an excessive reduction in blood pressure. This medication may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medication once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medication once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medication once daily is recommended (see Precautions). A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Pediatric and adolescent patients 6 years of age and older, weighing 20 kg or more but less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medication once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Pediatric and adolescent patients 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medication once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters. If pregnancy is confirmed, it must be stopped immediately. Women who may become pregnant or who are pregnant should not use this medication, and if pregnancy is discovered while taking it, they should consult a doctor immediately. Use is prohibited in patients with liver or kidney dysfunction, hereditary angioedema, or certain lactose intolerance. Caution is advised when using this medication in elderly patients, patients with elevated serum potassium levels, and those with liver impairment, requiring regular blood tests and monitoring. This medication lowers blood pressure, so patients at risk of hypotension or renal failure should be cautious during use and report any symptoms immediately. The risk of side effects may increase when combined with other antihypertensives or potassium-sparing diuretics, so consultation with a doctor is essential. Sudden dizziness or loss of consciousness may occur while taking this medication, so caution should be exercised when driving or operating machinery. In cases of overdose, low blood pressure and cardiac arrhythmias may occur, necessitating immediate medical attention. This medication is not to be used in children, particularly in those under 6 years of age or children with severely impaired kidney function. Any unusual symptoms or discomfort should be reported immediately, and women who are pregnant or planning to become pregnant should consult a doctor.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to store it at room temperature between 1°C and 30°C. This helps maintain the medication's effectiveness for a longer time.
White oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 50mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.